Lgr4 and Lgr5 are known markers of adult and embryonic tissue stem cells in various organs. However, whether Lgr4 and Lgr5 are important for embryonic development remains unclear. To study their functions during intestinal crypt, skin and kidney development we now generated mice lacking either Lgr4 (Lgr4KO), Lgr5 (Lgr5KO) or both receptors (Lgr4/5dKO). E16.5 Lgr4KO mice displayed complete loss of Lgr5+/Olfm4+intestinal stem cells, compromised Wnt signaling and impaired proliferation and differentiation of gut epithelium. Similarly, E16.5 Lgr4KO mice showed reduced basal cell proliferation and hair follicle numbers in the developing skin, as well as dilated kidney tubules and ectatic Bowman׳s spaces. Although Lgr4KO and Lgr5KO mice both died perinatally, Lgr5 deletion did not compromise embryonic development of gut, kidney or skin. Concomitant deletion of Lgr4 and Lgr5 did not prevent perinatal lethality, in contrast to a previous report that suggested rescue of Lgr5 KO perinatal lethality by a hypomorphic Lgr4 mutant. While the double deletion did not further promote the phenotypes observed in Lgr4KO intestines, impaired kidney cell proliferation, reduced epidermal thickness, loss of Lgr5+follicular epithelium and impaired hair follicle development were only observed in Lgr4/5dKO mice. This supports complementary functions of both receptors. Our findings clearly establish the importance of Lgr4 and Lgr5 during embryonic gut, skin and kidney development, with a dominant role of Lgr4.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ydbio.2014.03.009DOI Listing

Publication Analysis

Top Keywords

lgr4 lgr5
20
lgr5 embryonic
12
lgr4
8
lgr5
8
embryonic gut
8
gut kidney
8
kidney skin
8
stem cells
8
embryonic development
8
skin kidney
8

Similar Publications

The regulator of the canonical Wnt pathway, leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5), is expressed in the stem cell compartment of several tissues and overexpressed in different human carcinomas. The isoform of the stem cell marker LGR5, named LGR5Δ5 and first described by our group, is associated with prognosis and metastasis in oral squamous cell carcinoma (OSCC) and soft tissue sarcoma (STS). In a proof-of-principle analysis, the function of LGR5Δ5 was investigated in HEK293T cells, a model cell line of the Wnt pathway, compared to full-length LGR5 (FL) expression.

View Article and Find Full Text PDF

Stem Cell Markers LGR5, LGR4 and Their Immediate Signalling Partners are Dysregulated in Preeclampsia.

Stem Cell Rev Rep

December 2024

The Department of Obstetrics, Gynaecology and Newborn Health/Mercy Hospital for Women, University of Melbourne, 163 Studley Road, Heidelberg, Victoria, 3084, Australia.

Leucine-rich repeat-containing G protein-coupled receptors 5/4 (LGR5/LGR4) are critical stem cell markers in epithelial tissues including intestine. They agonise wingless-related integration site (WNT) signalling. Until now, LGR5/LGR4 were uncharacterised in placenta, where analogous functions may exist.

View Article and Find Full Text PDF

In the dentate gyrus of the adult hippocampus, neurogenesis from neural stem cells (NSCs) is regulated by Wnt signals from the local microenvironment. The Wnt/β-catenin pathway is active in NSCs, where it regulates proliferation and fate commitment, and subsequently its activity is strongly attenuated. The mechanisms controlling Wnt activity are poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Antibody-drug conjugates (ADCs) are a promising targeted cancer treatment, but none have been approved specifically for colorectal cancer (CRC) yet.
  • LGR4/5/6 receptors are commonly found in CRC, and while ADCs targeting LGR5 show strong anti-tumor effects, not all CRC cells express LGR5, leading to challenges.
  • A new drug conjugate, R462-CPT2, combines a modified RSPO4 protein with a potent drug and has displayed effective anti-tumor activity in CRC models without significant side effects, making it a strong candidate for CRC therapy.
View Article and Find Full Text PDF
Article Synopsis
  • - Mitochondrial dysfunction in inflammatory bowel disease (IBD) leads to increased oxygen levels in the gut, fostering the growth of certain bacteria and disrupting the balance of the microbiome, which can harm metabolism and immunity.
  • - A novel compound called AuPhos enhances mitochondrial function in intestinal cells, reduces colitis symptoms, and restores a healthy gut microbiome in mice models, implying its potential benefits for IBD patients.
  • - The study utilized various experimental methods, including animal models and human tissue analyses, showing that AuPhos alters microbial composition and improves oxygen use in gut cells, indicating its role in correcting IBD-related metabolic issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!